Home » Topics » Regulatory

Regulatory
RSS

Avandia approved in Mexico, approval recommended in U.S.

April 23, 1999

Amoxil cleared for b.i.d. dosing in children

April 22, 1999

FDA grants priority review status to Alza' sNDA for Doxil in ovarian cancer

April 20, 1999

European Commission approves novel albumin-free treatment for hemophilia A

April 19, 1999

Furosemide prevents sound-induced seizures in rat model

April 19, 1999

FDA approves amprenavir, first new protease inhibitor in more than two years

April 19, 1999

Higher dose of Rebif approved in E.U. for multiple sclerosis

April 15, 1999

In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting

April 15, 1999

FDA approves Fragmin for DVT after hip replacement surgery

April 13, 1999

SangStat's ciclosporin capsules filed for approval in U.K.

April 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...